Skip to main content
Premium Trial:

Request an Annual Quote

PE Says Affymetrix Infringes on Patents

Premium

PE Biosytems filed a law suit alleging that Affymetrix’s products infringe on five PE patented inventions.

In the lawsuit, filed in the US District Court in Delaware, PE alleged that Affymetrix “has long been aware of the patents” but nevertheless continued to make and sell its GeneChip Probe Array.

According to court papers, the alleged infringement concerns patents used to synthesize oligonucleotides and to speed up production of DNA.

In response, Vern Norviel, general counsel of Affymetrix said: “Affymetrix purchases its reagents from licensed vendors, therefore, we believe we have meritorious defenses to the claims in this lawsuit.”

PE of Norwalk, Conn., asked the court to block Affymetrix from further alleged infringement and to award unspecified damages.

Based in Santa Clara, Calif., Affymetrix’s gene chip technology allow researchers to analyze and manage genetic information. Glaxo Wellcome owns 22 percent of Affymetrix.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.